Evidence map›Paper›PMID 26272158›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2015

Critical Factors in the Assessment of Cholestatic Liver Injury In Vitro.

Benjamin L Woolbright, Hartmut Jaeschke

Open access · greenAbstract read
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact, top 74% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Prospect ofFrontiers in toxicology · 2021
    Review
  3. Cholestasis Differentially Affects Liver Connexins.International journal of molecular sciences · 2020
    Article
  4. Article
  5. Differential toxic effects of bile acid mixtures in isolated mitochondria and physiologically relevant HepaRG cells.Toxicology in vitro : an international journal published in association with BIBRA · 2019
    Article
  6. Review
  7. YAP Activation Drives Liver Regeneration after Cholestatic Damage Induced byInternational journal of molecular sciences · 2018
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Benjamin L WoolbrightDepartment of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, 3901 Rainbow Boulevard, MS1018, Kansas City, KS, 66160, USA.
Hartmut Jaeschke
University of Kansas Medical Center · US

Funding

Heartland Institute for Clinical and Translational ResearchUL1TR000001 · NCATS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI BAROHN, RICHARD J. · 2012 to 2015
$13.0M
THE ROLE OF HUMAN PXR IN ANTI-TUBERCULOSIS DRUG-INDUCED LIVER INJURYP20RR021940 · NCRR · UNIVERSITY OF KANSAS MEDICAL CENTER · PI APTE, UDAYAN · 2006 to 2011
$12.1M
Nuclear Receptors in Liver Health and DiseaseP20GM103549 · NIGMS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI JAESCHKE, HARTMUT W. · 2012 to 2015
$8.1M
TRAINING PROGRAM IN ENVIRONMENTAL TOXICOLOGYT32ES007079 · NIEHS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI HAGENBUCH, BRUNO · 1985 to 2015
$4.1M
HEARTLAND INSTITUTE FOR CLINICAL AND TRANSLATIONAL RESEARCHUL1RR033179 · NCRR · UNIVERSITY OF KANSAS MEDICAL CENTER · PI BAROHN, RICHARD J. · 2011 to 2011
$3.2M
NEUTROPHIL-INDUCED LIVER INJURY TOXICITYR01AA012916 · NIAAA · UNIVERSITY OF KANSAS MEDICAL CENTER · PI JAESCHKE, HARTMUT W. · 2001 to 2012
$2.9M
Heartland Institute for Clinical and Translational ResearchKL2TR000119 · NCATS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI BAROHN, RICHARD J. · 2012 to 2015
$2.5M
Mitochondrial Dysfunction and Drug HepatotoxicityR01DK070195 · NIDDK · UNIVERSITY OF KANSAS MEDICAL CENTER · PI JAESCHKE, HARTMUT W. · 2005 to 2010
$1.8M
Heartland Institute for Clinical and Translational ResearchKL2RR033177 · NCRR · UNIVERSITY OF KANSAS MEDICAL CENTER · PI BAROHN, RICHARD J. · 2011 to 2011
$653k
Heartland Institute for Clinical and Translational ResearchTL1TR000120 · NCATS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI BAROHN, RICHARD J. · 2012 to 2015
$549k
NCATS NIH HHS KL2 TR000119NCATS NIH HHS TL1 TR000120NCATS NIH HHS UL1 TR000001NCATS NIH HHS UL1TR000001NCRR NIH HHS 5P20RR021940NCRR NIH HHS KL2 RR033177NCRR NIH HHS P20 RR021940NCRR NIH HHS UL1 RR033179NCRR NIH HHS UL1RR033179NIAAA NIH HHS R01 AA012916NIAAA NIH HHS R01 AA12916NIDDK NIH HHS R01 DK070195NIEHS NIH HHS T32 ES007079NIEHS NIH HHS T32 ES007079-26A2NIGMS NIH HHS 8 P20 GM103549NIGMS NIH HHS P20 GM103549
6 · The paper itself

Abstract

Cholestasis is a common pathological component of numerous liver diseases. The initiating event during cholestatic liver injury is widely believed to be the accumulation of bile acids in hepatocytes and the hepatic parenchyma. As bile acids are considered the primary toxic compounds in the injury, numerous in vitro models of bile acid-induced injury and bile acid-induced changes in gene expression have been developed to attempt to better define cholestasis at a cellular level. This chapter focuses on the establishment of a system for determining the effects of cholestatic concentrations of bile acids on hepatocytes using primary hepatocytes or hepatoma cell lines. Moreover, this chapter addresses significant differences in the response of different species to bile acid exposure and novel information on the relevance of treating hepatocytes with concentrations of specific bile acids.

Indexed as

In Vitro TechniquesAlanine TransaminaseAnimalsBile Acids and SaltsCaspase 3Cell Culture TechniquesCell Line, TumorCholestasisHepatocytesHumansLactate DehydrogenasesAlanine TransaminaseBile Acids and SaltsCaspase 3Lactate Dehydrogenases

Identifiers

PMID26272158
PMCPMC4765948
OpenAlexW2442198207

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.